Open Access Open Access  Restricted Access Subscription Access

Signs, Symptoms, Mechanism of Action, Adverse Effects, Contra Indications and Toxicity of Benzathine Penicillin

Muralinath E., Munisekhar ., Lahari ., Prabhavathi P., Superna ., Harshita ., Rajeswari ., Gautam ., Sravani Pragna K., Guruprasad M.

Abstract


This activity investigates the various clinical uses of benzathine penicillin, a powerful antibiotic that is produced when penicillin G molecules combine with diphenylethylene diamine. Benzathine penicillin, which has broad-spectrum activity against gram-positive bacteria, is a powerful drug that effectively combats a variety of pathogens, including β-hemolytic streptococci. (groups A, B, C, G, H, L, and M). Benzathine penicillin is a cornerstone in the treatment of syphilis and yaws due to its remarkable effectiveness against Treponema pallidum and T. carateum. Crucially, the lack of documented resistance in Streptococcus pyogenes highlights its unmatched record and confirms its reputation as a trustworthy treatment for certain diseases.

This instructional program provides a thorough examination of benzathine penicillin, giving medical professionals a thorough understanding of its indications, dosage schedules, modes of administration, possible side effects, and particular contraindications. This CME activity intends to provide healthcare professionals with a better understanding of the clinical utility of benzathine penicillin by revealing its robust mechanism of action against different bacterial species. In order to effectively manage bacterial infections that are susceptible to this antibiotic, the objective is to maximize therapy options and encourage informed decision-making. In the end, participants will improve patient outcomes by gaining important knowledge to manage the subtleties of benzathine penicillin therapy.


Full Text:

PDF

References


Walker, G. J., Walker, D., Molano Franco, D., & Grillo-Ardila, C. F. (2019). Antibiotic treatment for newborns with congenital syphilis. Cochrane Database of Systematic Reviews, 2019(2), Article CD012071.

Ndeikoundam Ngangro, N., Viriot, D., Fournet, N., Pioche, C., De Barbeyrac, B., Goubard, A., Dupin, N., Berçot, B., Fouéré, S., Alcaraz, I., Ohayon, M., Spenatto, N., Vernay-Vaisse, C., Pillonel, J., & Lot, F. (2019). Bacterial sexually transmitted infections in France: Recent trends and patients' characteristics in 2016. Eurosurveillance, 24(5).

Webber, B. J., Kieffer, J. W., White, B. K., Hawksworth, A. W., Graf, P. C. F., & Yun, H. C. (2019). Chemoprophylaxis against group A streptococcus during military training. Preventive Medicine, 118, 142–149.

Struyve, M., Meersseman, W., & Van Moerkercke, W. (2018). Primary syphilitic proctitis: Case report and literature review. Acta Gastro-Enterologica Belgica, 81(3), 430–432.

Khan, A., Sutcliffe, N., & Jawad, A. S. (2018). An old disease re-emerging: Acute rheumatic fever. Clinical Medicine, 18(5), 400–402.

Gozdas, H. T., & Dogan, A. (2023). Is benzathine penicillin the treatment of choice in neurosyphilis? The American Journal of Medicine, 136(10), e208.

Dündaröz, R., Ulucan, H., Denli, M., Karapinar, K., Aydin, H. I., & Baltaci, V. (2001). Evaluation of DNA damage using the comet assay in children on long-term benzathine penicillin for secondary prophylaxis of rheumatic fever. Pediatric International, 43(3), 276–280.

Kingston, M., & Carlin, E. (2002). Treatment of sexually transmitted infections with single-dose therapy: A double-edged sword. Drugs, 62(6), 871–878.

Benzaken, A. S., Pereira, G. F. M., Cunha, A. R. C. D., Souza, F. M. A., & Saraceni, V. (2019). Adequacy of prenatal care, diagnosis and treatment of syphilis in pregnancy: A study with open data from Brazilian state capitals. Cadernos de Saúde Pública, 36(1), Article e00057219.

National Library of Medicine. (2024, August 15). Benzathine penicillin G. In Drugs and Lactation Database (LactMed®). National Center for Biotechnology Information.

Holland, J. V., Hardie, K., de Dassel, J., & Ralph, A. P. (2018). Rheumatic heart disease prophylaxis in older patients: A register-based audit of adherence to guidelines. Open Forum Infectious Diseases, 5(6), Article ofy125.

Montagnat, O. D., Webster, G. R., Bulitta, J. B., Landersdorfer, C., Wyber, R., Sheel, M., Carapetis, J. R., & Boyd, B. J. (2018). Lessons learned in the development of sustained release penicillin drug delivery systems for the prophylactic treatment of rheumatic heart disease (RHD). Drug Delivery and Translational Research, 8(3), 729–739.

Kaplan, M. I., Lee, J. A., Hovda, L. R., & Brutlag, A. (2011). Adverse effects associated with inadvertent intravenous penicillin G procaine-penicillin G benzathine administration in two dogs and a cat. Journal of the American Veterinary Medical Association, 238(4), 507–510.

Garcia, J. F. B., Aun, M. V., Motta, A. A., Castells, M., Kalil, J., & Giavina-Bianchi, P. (2021). Algorithm to guide re-exposure to penicillin in allergic pregnant women with syphilis: Efficacy and safety. The World Allergy Organization Journal, 14(6), Article 100549.


Refbacks

  • There are currently no refbacks.